Labcorp (NYSE: LH) EVP Anita Graham settles RSUs, withholds shares for tax

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Anita Z. Graham reported routine equity award activity. On February 11, 2026, 356 Restricted Stock Units converted into 356 shares of common stock at an exercise price of $0. To cover tax withholding, 109 shares of common stock were withheld at $289.89 per share. After these transactions, Graham directly owned 1,460 shares of common stock and 2,401 Restricted Stock Units, which continue to vest in three equal annual installments starting February 11, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GRAHAM ANITA Z

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CHRO

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		356	A	(1)	1,569	D
Common Stock	02/11/2026		F(2)		109	D	$289.89	1,460	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			356	(3)	(3)	Common Stock	356	$0	2,401(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Anita Z. Graham	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Labcorp (LH) report for Anita Z. Graham?

Labcorp reported that EVP, CHRO Anita Z. Graham converted 356 Restricted Stock Units into common shares, and had 109 shares withheld to satisfy tax obligations. These are routine equity award and tax withholding transactions disclosed in a Form 4 filing.

How many Labcorp (LH) shares does Anita Z. Graham own after the Form 4 transactions?

After the reported transactions, Anita Z. Graham directly owns 1,460 shares of Labcorp common stock. She also holds 2,401 Restricted Stock Units, representing a contingent right to receive an equal number of shares as they vest over time.

What type of equity award did Labcorp (LH) executive Anita Z. Graham exercise?

Anita Z. Graham exercised Restricted Stock Units (RSUs), converting 356 RSUs into 356 shares of Labcorp common stock at an exercise price of $0. Each RSU represents the right to receive one share upon vesting and settlement.

Why were 109 Labcorp (LH) shares disposed of in Anita Z. Graham’s Form 4?

The 109 shares shown as disposed of were withheld at $289.89 per share to satisfy tax withholding obligations related to the RSU vesting. This is a non‑open‑market, tax‑related disposition rather than a discretionary sale in the market.

How do Anita Z. Graham’s Labcorp (LH) RSUs vest after this transaction?

The vested RSUs were part of a grant that vests in three equal annual installments, beginning on February 11, 2026. Following the reported activity, Graham holds 2,401 RSUs in total, which will settle into shares as future installments vest.

Is Anita Z. Graham a director or officer of Labcorp (LH) in this Form 4?

In this Form 4, Anita Z. Graham is identified as an officer of Labcorp, serving as EVP, CHRO (Executive Vice President, Chief Human Resources Officer). She is not reported as a director or 10% owner in this filing.